StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd.

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.73+0.02 (+0.05%)

Close on Nov 18, 2026Market cap $27.98BP/E –Yield –

Roivant Sciences Covant Therapeutics — Basic Ownership Stake by Quarter

Covant Therapeutics — Basic Ownership Stake (%)

Periods

Roivant Sciences Covant Therapeutics — Basic Ownership Stake: 96.0% in Q2 FY2026, up 1.0 pts from a year earlier.

Latest, Q2 FY2026
96.0%
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
+1.0 pts
95.0% in Q2 FY2025
History
13 quarters
Since Q2 FY2022
Sources
13
Documents cited below

Where the Q2 FY2026 figure comes from

“|| Covant | 96 | % | 90 | %”

Source: Form 10-Q (roiv-20260930.htm, filed 2026-11-09) ↗

Reported in Form 10-K / 10-Q (Roivant Ownership Table).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCovant Therapeutics — Basic Ownership Stake (%)Year on yearSource
Q2 FY2026CQ3 2026Sep 30, 202696.0%+1.0 ptsForm 10-Q (roiv-20260930.htm, filed 2026-11-09) ↗
Q1 FY2026CQ2 2026Jun 30, 202696.0%–Form 10-Q (roiv-20260630.htm, filed 2026-08-06) ↗
Q4 FY2025CQ1 2026Mar 31, 202694.0%–Form 10-K (roiv-20260331.htm, filed 2026-05-20) ↗
Q3 FY2025CQ4 2025Dec 31, 202595.0%–Form 10-Q (roiv-20251231.htm, filed 2026-02-06) ↗
Q2 FY2025CQ3 2025Sep 30, 202595.0%–Form 10-Q (roiv-20250930.htm, filed 2025-11-10) ↗
Q1 FY2024CQ2 2024Jun 30, 2024100.0%0.0 ptsForm 10-Q (ef20030921_10q.htm, filed 2024-08-09) ↗
Q4 FY2023CQ1 2024Mar 31, 2024100.0%0.0 ptsForm 10-K (ef20026301_10k.htm, filed 2024-05-30) ↗
Q3 FY2023CQ4 2023Dec 31, 2023100.0%0.0 ptsForm 10-Q (ef20015327_10q.htm, filed 2024-02-13) ↗
Q2 FY2023CQ3 2023Sep 30, 2023100.0%0.0 ptsForm 10-Q (ef20012491_10q.htm, filed 2023-11-13) ↗
Q1 FY2023CQ2 2023Jun 30, 2023100.0%–Form 10-Q (brhc20057263_10q.htm, filed 2023-08-14) ↗
Q4 FY2022CQ1 2023Mar 31, 2023100.0%–Form 10-K (brhc20054745_10k.htm, filed 2023-06-28) ↗
Q3 FY2022CQ4 2022Dec 31, 2022100.0%–Form 10-Q (brhc10047697_10q.htm, filed 2023-02-13) ↗
Q2 FY2022CQ3 2022Sep 30, 2022100.0%–Form 10-Q (brhc10044005_10q.htm, filed 2022-11-14) ↗

Breakdown

What makes up covant Therapeutics — Basic Ownership Stake

Cite this data

StockData. (2026). Roivant Sciences Covant Therapeutics — Basic Ownership Stake (%), quarterly Q2 FY2022–Q2 FY2026 [Data set]. Compiled from Roivant Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/roiv/kpis/own-covant-basic

See every metric in the Roivant Sciences KPI table. Data updated Nov 16, 2026.

See a number that looks wrong?